v3.26.3
Share-based Compensation
6 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Share-based Compensation Share-based Compensation
The following table summarizes the components of total share-based compensation expense included in the condensed consolidated statements of operations for each period presented (in thousands):
Three Months Ended September 30,Six Months Ended September 30,
2026202520262025
Cost of revenue$10,394 $10,015 $19,760 $19,865 
Research and development30,648 29,718 60,164 56,579 
Sales and marketing21,609 22,576 41,496 42,610 
General and administrative15,510 14,505 30,317 29,655 
Total share-based compensation$78,161 $76,814 $151,737 $148,709 
Amended and Restated 2019 Equity Incentive Plan
In July 2019, the Company’s Board of Directors (the “Board”), upon the recommendation of the Compensation Committee of the Board, adopted the 2019 Equity Incentive Plan (the “Equity Incentive Plan”), which was subsequently approved by the Company’s stockholders and was later amended and restated by the Board in January 2021.
The Company initially reserved 52,000,000 shares of common stock for the issuance of awards under the Equity Incentive Plan. The Equity Incentive Plan provides that the number of shares reserved and available for issuance under the plan automatically increases each April 1 by 4% of the outstanding number of shares of the Company’s common stock on the immediately preceding March 31 or such lesser number determined by the Compensation Committee. This number is subject to adjustment in the event of a stock split, stock dividend or other change in the Company’s capitalization. As of September 30, 2026, 68,476,722 shares of common stock were available for future issuance under the Equity Incentive Plan.
Restricted shares and units
The following table provides a summary of changes in the number of RSUs and restricted stock awards (“RSAs”) for the six months ended September 30, 2026:
Number of RSUs
Weighted Average
Grant Date Fair Value
Number of
 RSAs
Weighted Average
Grant Date Fair Value
(in thousands)(per share)(in thousands)(per share)
Balance, March 31, 202610,403 $51.96 61 $49.05 
Granted7,147 43.10 — — 
Vested(3,583)52.04 (30)49.05 
Forfeited(826)52.69 — — 
Balance, September 30, 202613,141 $47.06 31 $49.05 
RSUs outstanding as of September 30, 2026 were comprised of 11.9 million RSUs with only service conditions and 1.2 million RSUs with both service and performance or market-based conditions (“PSUs”).
The Company grants PSUs that contain financial performance conditions (“Financial PSUs”) and PSUs based on relative total stockholder return performance (“rTSR PSUs”). Both the Financial PSUs and rTSR PSUs are not earned if the applicable threshold percentage of the specific metric is not achieved. The maximum number of shares that may be earned is 200% of the target award. The PSUs are also subject to time-based vesting and are contingent upon the employee remaining employed by the Company or one of its subsidiaries through the applicable vesting dates.
The Financial PSUs generally vest 33% one year after the grant date and the remaining 67% vest ratably on a quarterly basis over the following two years. The number of shares that may be earned pursuant to the Financial PSUs is based on specific Company metrics related to the fiscal year in which the award was granted.
The rTSR PSUs generally vest 33% annually after the grant date. The number of shares that may be earned pursuant to the rTSR PSUs granted is based on the Company’s stock price performance relative to companies that are the constituents of the Russell 3000 index over performance periods of one, two, and three fiscal years.
As of September 30, 2026, the total unrecognized compensation expense related to unvested RSUs was $535.6 million and is expected to be recognized over a weighted average period of 2.3 years. As of September 30, 2026, the total unrecognized compensation expense related to unvested RSAs was $0.9 million and is expected to be recognized over a weighted average period of 0.4 years.
Stock options
The Company has not granted new stock options since fiscal 2022. The following table summarizes activity for stock options during the six months ended September 30, 2026:
Number of Options
Weighted Average
Exercise Price
Weighted Average Remaining Contractual Term Aggregate Intrinsic Value
(in thousands)(per share)(years)(in thousands)
Balance, March 31, 20261,727 $22.11 
Exercised(243)21.29 
Forfeited or expired(4)49.68 
Balance, September 30, 20261,480 $22.18 3.0$52,634 
Options vested and expected to vest at September 30, 20261,480 $22.18 3.0$52,634 
Options vested and exercisable at September 30, 20261,480 $22.18 3.0$52,634 
As of September 30, 2026, there was no unrecognized compensation expense related to non-vested stock options.
Employee Stock Purchase Plan
In July 2019, the Board adopted, and the Company’s stockholders approved, the 2019 Employee Stock Purchase Plan (the “ESPP”). The Company offers, sells, and issues shares of common stock under the ESPP from time to time based on various factors and conditions, although the Company is under no obligation to sell any shares under the ESPP. The ESPP provides for six-month offering periods and each offering period consists of six-month purchase periods. On each purchase date, eligible employees purchase shares of the Company’s common stock at a price per share equal to 85% of the lesser of (1) the fair market value of the Company’s common stock on the offering date or (2) the fair market value of the Company’s common stock on the purchase date. During the six months ended September 30, 2026, 352,344 shares of common stock were purchased under the ESPP. As of September 30, 2026, 23,311,662 shares of common stock were available for future issuance under the ESPP.
As of September 30, 2026, there was $1.7 million of unrecognized share-based compensation related to the ESPP that is expected to be recognized over the remaining term of the current offering period.